QuadMix Injectable Recalled for Lack of Sterility Assurance
Axium Healthcare Pharmacy is recalling QuadMix Injectable due to lack of sterility assurance and quality control concerns.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury risks or hospitalization reports.
Plain-English summary
Axium Healthcare Pharmacy, doing business as Balanced Solutions Compounding, is recalling all lots of QuadMix Injectable. The product consists of 3 vials (10 mL each) and was distributed in Colorado, Georgia, Michigan, and Puerto Rico.
The recall was initiated because the compounding pharmacy could not ensure the sterility of the products it compounded, repackaged, and distributed. The agency cited concerns associated with the pharmacy's quality control processes.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.
The recalled product
- Product
- QuadMix Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- ALL Lots
Distribution
Part of a larger recall action
This product is one of 26 recalled by Axium Healthcare Pharmacy dba Balanced Solutions Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · Axium Healthcare Pharmacy dba Balanced Solutions Compounding
See all →- SevereFDA Recalls Triamcinolone Diacetate Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereFDA Recalls Methylcobalamin and Folic Acid Injectables Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereMethylprednisolone Acetate Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2013-05-01
- SevereProgesterone Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
- SevereBiMix Standard Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22